Neurogene Inc. · NASDAQ:NGNE
Trails Edge Capital Partners, LP reported a 5.10% stake in Neurogene Inc. (Schedule 13G)
Event Dec 8, 2025 · Filed Dec 15, 2025
Trails Edge Capital Partners, LP reported a 5.10% stake in Neurogene Inc., 785,000 shares, as a passive investor on Dec 8, 2025. Filed Dec 15, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 785,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 5.10% | 785,000 |
| Trails Edge Biotechnology Master Fund, LP | 5.10% | 785,000 |
| Ortav Yehudai | 5.10% | 785,000 |
Source
Related
- Neurogene Inc.
- Trails Edge Capital Partners, LP
- Neurogene Inc. shareholders
- Schedule 13G/A · Trails Edge Capital Partners, LP · Aug 14, 2026
- Schedule 13G · Prudential Financial Inc · Oct 7, 2026
- Schedule 13G · Jennison Associates LLC · Oct 6, 2026
- Form 4 · McMinn Rachel · Oct 2, 2026
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026